Skin Tight: Dermatology Specialty Leo Pharma To Buy Peplin for $287.5 Million
The dermatology market is increasingly attractive for deal makers, as Leo's all-cash acquisition of Peplin demonstrates.
The dermatology market is increasingly attractive for deal makers, as Leo's all-cash acquisition of Peplin demonstrates.